{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:44:00Z","timestamp":1790631840983,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["18783"],"award-info":[{"award-number":["18783"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20299"],"award-info":[{"award-number":["20299"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["17927"],"award-info":[{"award-number":["17927"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13045-018-0689-y","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T18:02:55Z","timestamp":1546970575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis"],"prefix":"10.1186","volume":"12","author":[{"given":"Stefania","family":"Raimondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Saieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Toscani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Manno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Raccosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-1040","authenticated-orcid":false,"given":"Riccardo","family":"Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"issue":"6","key":"689_CR1","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","volume":"17","author":"N Raje","year":"2011","unstructured":"Raje N, Roodman GD. Advances in the biology and treatment of bone disease in multiple myeloma. Clin Cancer Res. 2011;17(6):1278\u201386.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"689_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2174\/156800912802429300","volume":"12","author":"M Rossi","year":"2012","unstructured":"Rossi M, Di Martino MT, Morelli E, Leotta M, Rizzo A, Grimaldi A, et al. Molecular targets for the treatment of multiple myeloma. Curr Cancer Drug Targets. 2012;12(7):757\u201367.","journal-title":"Curr Cancer Drug Targets"},{"issue":"13","key":"689_CR3","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","volume":"108","author":"N Giuliani","year":"2006","unstructured":"Giuliani N, Rizzoli V, Roodman GD. Multiple myeloma bone disease: pathophysiology of osteoblast inhibition. Blood. 2006;108(13):3992\u20136.","journal-title":"Blood"},{"key":"689_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4137\/CGM.S16817","volume":"7","author":"A Hameed","year":"2014","unstructured":"Hameed A, Brady JJ, Dowling P, Clynes M, O\u2019Gorman P. Bone disease in multiple myeloma: pathophysiology and management. Cancer Growth Metastasis. 2014;7:33\u201342.","journal-title":"Cancer Growth Metastasis"},{"issue":"1","key":"689_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","volume":"8","author":"E Terpos","year":"2018","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, Dimopoulos MA. Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 2018;8(1):7.","journal-title":"Blood Cancer J"},{"key":"689_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4614-4666-8_9","volume-title":"Advances in biology and therapy of multiple myeloma: volume 1: basic science","author":"DL Galson","year":"2013","unstructured":"Galson DL, D\u2019Souza S, Osteoclasts RGD. Potential target for blocking microenvironmental support of myeloma. In: Munshi NC, Anderson KC, editors. Advances in biology and therapy of multiple myeloma: volume 1: basic science. New York: Springer New York; 2013. p. 169\u201385."},{"key":"689_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bone.2015.02.021","volume":"75","author":"MR Reagan","year":"2015","unstructured":"Reagan MR, Liaw L, Rosen CJ, Ghobrial IM. Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast. Bone. 2015 Jun;75:161\u20139.","journal-title":"Bone"},{"issue":"4","key":"689_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5114\/aoms.2010.14459","volume":"6","author":"J Fu","year":"2010","unstructured":"Fu J, Wang P, Zhang X, Ju S, Li J, Li B, et al. Myeloma cells inhibit osteogenic differentiation of mesenchymal stem cells and kill osteoblasts via TRAIL-induced apoptosis. Arch Med Sci. 2010;6(4):496\u2013504.","journal-title":"Arch Med Sci"},{"issue":"3","key":"689_CR9","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/ijms14035338","volume":"14","author":"C Corrado","year":"2013","unstructured":"Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14(3):5338\u201366.","journal-title":"Int J Mol Sci"},{"key":"689_CR10","doi-asserted-by":"publisher","first-page":"821613","DOI":"10.1155\/2015\/821613","volume":"2015","author":"S Raimondo","year":"2015","unstructured":"Raimondo S, Corrado C, Raimondi L, De Leo G, Alessandro R. Role of extracellular vesicles in hematological malignancies. Biomed Res Int. 2015;2015:821613.","journal-title":"Biomed Res Int"},{"issue":"14","key":"689_CR11","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.18632\/oncotarget.2159","volume":"5","author":"BK Arendt","year":"2014","unstructured":"Arendt BK, Walters DK, Wu X, Tschumper RC, Jelinek DF. Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation. Oncotarget. 2014;5(14):5686\u201399.","journal-title":"Oncotarget"},{"issue":"25","key":"689_CR12","doi-asserted-by":"crossref","first-page":"38927","DOI":"10.18632\/oncotarget.7792","volume":"7","author":"J Wang","year":"2016","unstructured":"Wang J, Faict S, Maes K, De Bruyne E, Van Valckenborgh E, Schots R, et al. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma. Oncotarget. 2016;7(25):38927\u201345.","journal-title":"Oncotarget"},{"issue":"2","key":"689_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/aps.2013.141","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, Zhu XJ, Zeng C, Wu PH, Wang HX, Chen ZC, et al. Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharmacol Sin. 2014;35(2):230\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"25","key":"689_CR14","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","volume":"124","author":"T Umezu","year":"2014","unstructured":"Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014;124(25):3748\u201357.","journal-title":"Blood"},{"issue":"4","key":"689_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI66517","volume":"123","author":"AM Roccaro","year":"2013","unstructured":"Roccaro AM, Sacco A, Maiso P, Azab AK, Tai YT, Reagan M, et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest. 2013;123(4):1542\u201355.","journal-title":"J Clin Invest"},{"issue":"15","key":"689_CR16","doi-asserted-by":"publisher","first-page":"13772","DOI":"10.18632\/oncotarget.3830","volume":"6","author":"L Raimondi","year":"2015","unstructured":"Raimondi L, De Luca A, Amodio N, Manno M, Raccosta S, Taverna S, et al. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget. 2015;6(15):13772\u201389.","journal-title":"Oncotarget"},{"issue":"2","key":"689_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jcp.21511","volume":"217","author":"T Yi","year":"2008","unstructured":"Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, et al. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J Cell Physiol. 2008;217(2):409\u201322.","journal-title":"J Cell Physiol"},{"issue":"37","key":"689_CR18","doi-asserted-by":"publisher","first-page":"26656","DOI":"10.1074\/jbc.M705064200","volume":"282","author":"J Zhu","year":"2007","unstructured":"Zhu J, Jia X, Xiao G, Kang Y, Partridge NC, Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem. 2007;282(37):26656\u201364.","journal-title":"J Biol Chem"},{"issue":"9","key":"689_CR19","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/ijc.25562","volume":"128","author":"Y Ning","year":"2011","unstructured":"Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, Lurje G, et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer. 2011;128(9):2038\u201349.","journal-title":"Int J Cancer"},{"issue":"1","key":"689_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","volume":"33","author":"MS Bendre","year":"2003","unstructured":"Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone. 2003;33(1):28\u201337.","journal-title":"Bone"},{"issue":"8","key":"689_CR21","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.ajpath.2016.04.003","volume":"186","author":"AB Herrero","year":"2016","unstructured":"Herrero AB, Garcia-Gomez A, Garayoa M, Corchete LA, Hernandez JM, San Miguel J, et al. Effects of IL-8 up-regulation on cell survival and osteoclastogenesis in multiple myeloma. Am J Pathol. 2016;186(8):2171\u201382.","journal-title":"Am J Pathol"},{"issue":"7","key":"689_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/gcc.20668","volume":"48","author":"L Agnelli","year":"2009","unstructured":"Agnelli L, Mosca L, Fabris S, Lionetti M, Andronache A, Kwee I, et al. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect. Genes Chromosomes Cancer. 2009;48(7):603\u201314.","journal-title":"Genes Chromosomes Cancer"},{"issue":"23","key":"689_CR23","doi-asserted-by":"publisher","first-page":"7402","DOI":"10.1158\/1078-0432.CCR-11-0596","volume":"17","author":"L Agnelli","year":"2011","unstructured":"Agnelli L, Forcato M, Ferrari F, Tuana G, Todoerti K, Walker BA, et al. The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma. Clin Cancer Res. 2011;17(23):7402\u201312.","journal-title":"Clin Cancer Res"},{"issue":"34","key":"689_CR24","doi-asserted-by":"publisher","first-page":"56598","DOI":"10.18632\/oncotarget.17896","volume":"8","author":"F Costa","year":"2017","unstructured":"Costa F, Toscani D, Chillemi A, Quarona V, Bolzoni M, Marchica V, et al. Expression of CD38 in myeloma bone niche: a rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation. Oncotarget. 2017;8(34):56598\u2013611.","journal-title":"Oncotarget"},{"key":"689_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12964-015-0086-x","volume":"13","author":"S Raimondo","year":"2015","unstructured":"Raimondo S, Saieva L, Corrado C, Fontana S, Flugy A, Rizzo A, et al. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Cell Commun Signal. 2015;13:8.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"689_CR26","doi-asserted-by":"publisher","first-page":"e32444","DOI":"10.1371\/journal.pone.0032444","volume":"7","author":"R Noto","year":"2012","unstructured":"Noto R, Santangelo MG, Ricagno S, Mangione MR, Levantino M, Pezzullo M, et al. The tempered polymerization of human neuroserpin. PLoS One. 2012;7(3):e32444.","journal-title":"PLoS One"},{"issue":"1\u20132","key":"689_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","volume":"348","author":"C Corrado","year":"2014","unstructured":"Corrado C, Raimondo S, Saieva L, Flugy AM, De Leo G, Alessandro R. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett. 2014;348(1\u20132):71\u20136.","journal-title":"Cancer Lett"},{"issue":"4","key":"689_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bcp.2014.03.010","volume":"89","author":"CH Hou","year":"2014","unstructured":"Hou CH, Lin FL, Tong KB, Hou SM, Liu JF. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K\/Akt signaling pathway. Biochem Pharmacol. 2014;89(4):453\u201363.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"689_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jcp.21260","volume":"214","author":"A Luca De","year":"2008","unstructured":"De Luca A, Carotenuto A, Rachiglio A, Gallo M, Maiello MR, Aldinucci D, et al. The role of the EGFR signaling in tumor microenvironment. J Cell Physiol. 2008;214(3):559\u201367.","journal-title":"J Cell Physiol"},{"key":"689_CR30","doi-asserted-by":"publisher","unstructured":"Mercatali L, La Manna F, Miserocchi G, Liverani C, De Vita A, Spadazzi C, et al. Tumor-stroma crosstalk in bone tissue: the osteoclastogenic potential of a breast cancer cell line in a co-culture system and the role of EGFR inhibition. Int J Mol Sci. 2017;18(8):1655. https:\/\/doi.org\/10.3390\/ijms18081655 .","DOI":"10.3390\/ijms18081655"},{"issue":"51","key":"689_CR31","doi-asserted-by":"publisher","first-page":"53848","DOI":"10.1074\/jbc.M403114200","volume":"279","author":"K Wang","year":"2004","unstructured":"Wang K, Yamamoto H, Chin JR, Werb Z, Vu TH. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem. 2004;279(51):53848\u201356.","journal-title":"J Biol Chem"},{"issue":"21","key":"689_CR32","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1038\/sj.onc.1208536","volume":"24","author":"K Mahtouk","year":"2005","unstructured":"Mahtouk K, Hose D, Reme T, De Vos J, Jourdan M, Moreaux J, et al. Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene. 2005;24(21):3512\u201324.","journal-title":"Oncogene"},{"issue":"9","key":"689_CR33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cub.2011.03.043","volume":"21","author":"JN Higginbotham","year":"2011","unstructured":"Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, et al. Amphiregulin exosomes increase cancer cell invasion. Curr Biol. 2011;21(9):779\u201386.","journal-title":"Curr Biol"},{"issue":"1","key":"689_CR34","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1038\/s41598-017-03460-y","volume":"7","author":"S Taverna","year":"2017","unstructured":"Taverna S, Pucci M, Giallombardo M, Di Bella MA, Santarpia M, Reclusa P, et al. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway. Sci Rep. 2017;7(1):3170.","journal-title":"Sci Rep"},{"issue":"10","key":"689_CR35","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/jcmm.12873","volume":"20","author":"C Corrado","year":"2016","unstructured":"Corrado C, Saieva L, Raimondo S, Santoro A, De Leo G, Alessandro R. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. J Cell Mol Med. 2016;20(10):1829\u201339.","journal-title":"J Cell Mol Med"},{"issue":"13","key":"689_CR36","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","volume":"98","author":"N Giuliani","year":"2001","unstructured":"Giuliani N, Bataille R, Mancini C, Lazzaretti M, Barille S. Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment. Blood. 2001;98(13):3527\u201333.","journal-title":"Blood"},{"key":"689_CR37","doi-asserted-by":"crossref","unstructured":"Kumar B, Garcia M, Weng L, Jung X, Murakami JL, Hu X, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2017.","DOI":"10.1038\/leu.2017.259"},{"key":"689_CR38","doi-asserted-by":"publisher","unstructured":"Li B, Xu H, Han H, Song S, Zhang X, Ouyang L, et al. Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 2018;37(41):5508-19. https:\/\/doi.org\/10.1038\/s41388-018-0359-0 .","DOI":"10.1038\/s41388-018-0359-0"},{"issue":"7","key":"689_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10585-011-9398-4","volume":"28","author":"K Furugaki","year":"2011","unstructured":"Furugaki K, Moriya Y, Iwai T, Yorozu K, Yanagisawa M, Kondoh K, et al. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292. Clin Exp Metastasis. 2011;28(7):649\u201359.","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"689_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1677\/erc.1.00956","volume":"12","author":"N Normanno","year":"2005","unstructured":"Normanno N, De Luca A, Aldinucci D, Maiello MR, Mancino M, D'Antonio A, et al. Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis. Endocr Relat Cancer. 2005;12(2):471\u201382.","journal-title":"Endocr Relat Cancer"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-018-0689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13045-018-0689-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-018-0689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:20:27Z","timestamp":1606004427000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-018-0689-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1186\/s13045-018-0689-y","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"3 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in full conformance with the principles of the Declaration of Helsinki. All patients provided written informed consent. The Institutional Review Board of the University of Parma (Italy) approved this part of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest exists.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"2"}}